Citation: . Immune effectors required for the therapeutic activity of vorinostat. OncoImmunology 2013; 2:e27157; 10.4161/onci.27157
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Open access
Citation: . Immune effectors required for the therapeutic activity of vorinostat. OncoImmunology 2013; 2:e27157; 10.4161/onci.27157
No potential conflicts of interest were disclosed.
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more